Development of an intranasal vaccine for SARS-CoV-2 [electronic resource] / Scot Roberts.

By: Roberts, Scot [spk]Material type: SoundSoundSeries: Henry Stewart talksBiomedical & life sciences collection. Interviews on Covid-19: Publisher: London : Henry Stewart Talks, 2020Description: 1 online resource (1 streaming audio file (15 min.))Subject(s): Adenoviruses | Coronavirus infections -- Immunological aspects | COVID-19 (Disease) -- Vaccination | Transdermal medication | Vaccines -- Development | Viral vaccines | Adenoviridae | Administration, Intranasal | Betacoronavirus -- drug effects | Coronavirus Infections | COVID-19 Vaccines | COVID-19 -- immunology | COVID-19 -- prevention & control | Drug Development -- methods | Genetic Vectors | SARS-CoV-2 | Vaccines, DNAOnline resources: Click here to access online | Series
Contents:
Contents: General mechanism of action of DNA vaccines -- Adenoviral vectors for DNA delivery to host cells -- Advantages and limitations of intranasal vaccines -- Cellular, mucosal and antibody immunity in the context of SARS-2 -- Stability of AdCOVID at room temperature -- Earliest possible approval of AdCOVID -- How far and how fast can this vaccine then be deployed?
Tags from this library: No tags from this library for this title. Log in to add tags.
    Average rating: 0.0 (0 votes)
No physical items for this record

Audio interview.

Title from title frames.

Contents: General mechanism of action of DNA vaccines -- Adenoviral vectors for DNA delivery to host cells -- Advantages and limitations of intranasal vaccines -- Cellular, mucosal and antibody immunity in the context of SARS-2 -- Stability of AdCOVID at room temperature -- Earliest possible approval of AdCOVID -- How far and how fast can this vaccine then be deployed?

Access restricted to subscribers.

Mode of access: World Wide Web.

Technical University of Mombasa
Tom Mboya Street, Tudor 90420-80100 , Mombasa Kenya
Tel: (254)41-2492222/3 Fax: 2490571